MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Applied Nutrition eyes market share gains as sales meet raised outlook

ALN

Applied Nutrition PLC on Monday reported a double-digit increase in pretax profit, and sales at the top of recently raised guidance, led by strong growth in the UK and Europe.

Despite this, shares in the Liverpool-based sports nutrition brand fell 1.1% to 180.00 pence each in London on Monday morning, for a market value of £451.50 million. They have risen 29% in the last 12 months.

Applied Nutrition was admitted to trading on the London Stock Exchange’s Main Market on October, 2024. The initial public offering was priced at 140 pence per share, valuing it at around £350 million.

The company said pretax profit rose 17% to £28.5 million in the financial year ended July 31 from £24.3 million the year prior, with revenue increasing 24% to £107.1 million from £86.2 million.

Basic and diluted earnings per share grew 12% to 8.4 pence from 7.5p, or by 14% to 9.1p from 8.0p on an adjusted basis.

Applied Nutrition said sales were ahead of IPO guidance and in line with recently upgraded expectations of £107 million provided in August.

All geographies saw an increase in sales during the financial year, with UK sales up 44%, Europe up 46% and International up a more modest 2.9%.

Applied Nutrition expects International sales to grow more in financial 2026, noting sales in the second half of financial 2025 were 19% higher than the first half.

Adjusted earnings before interest, tax, depreciation and amortisation climbed 19% to £30.9 million from £26.0 million, ahead of IPO guidance, with unadjusted operating profit up 19% to £28.1 million from £23.7 million.

Applied Nutrition said the strong acceleration in sales growth in the final quarter of financial 2025 has continued into the first quarter of the new financial year.

‘We move into [financial 2026] with positive trends in market share across key channels, with a clear opportunity to capture further share in both the UK and internationally,’ the firm said.

Given it is ‘still early in the financial year’, the company left expectations for financial 2026 ‘unchanged at this stage.’

Over the next 18 to 24 months the firm intends to invest around £2.0 million to £2.5 million to ensure the business has the operations to support its continued expansion, drive efficiencies and reduce reliance on outsourced providers.

The investment is expected to increase capacity to £300 million.

‘Further investment will be assessed on a case-by-case basis where volume requirements and payback meet our criteria,’ the firm added.

Chief Executive Thomas Ryder said the company ‘over-delivered on targets set at IPO’ and remains focused on expanding globally.

Copyright 2025 Alliance News Ltd. All Rights Reserved.